Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Faecal phageome of healthy individuals: presence of antibiotic resistance genes and variations caused by ciprofloxacin treatment.

Fernández-Orth D, Miró E, Brown-Jaque M, Rodríguez-Rubio L, Espinal P, Rodriguez-Navarro J, González-López JJ, Muniesa M, Navarro F.

J Antimicrob Chemother. 2019 Apr 1;74(4):854-864. doi: 10.1093/jac/dky540.

PMID:
30649322
2.

Relationship Between Different Resistance Mechanisms and Virulence in Acinetobacter baumannii.

Espinal P, Pantel A, Rolo D, Marti S, López-Rojas R, Smani Y, Pachón J, Vila J, Lavigne JP.

Microb Drug Resist. 2019 Jun;25(5):752-760. doi: 10.1089/mdr.2018.0182. Epub 2019 Jan 11.

PMID:
30632884
3.

Genomics of Klebsiella pneumoniae ST16 producing NDM-1, CTX-M-15, and OXA-232.

Espinal P, Nucleo E, Caltagirone M, Mattioni Marchetti V, Fernandes MR, Biscaro V, Rigoli R, Carattoli A, Migliavacca R, Villa L.

Clin Microbiol Infect. 2019 Mar;25(3):385.e1-385.e5. doi: 10.1016/j.cmi.2018.11.004. Epub 2018 Nov 22.

PMID:
30472424
4.

[Small cell bladder carcinoma in age extremes: Report of two cases.]

Vallejo-Benítez A, Rodríguez-Zarco E, Pabón-Carrasco S, Espinal PS.

Arch Esp Urol. 2018 Mar;71(2):204-207. Spanish.

PMID:
29521267
5.

Antibiotic resistance genes in phage particles isolated from human faeces and induced from clinical bacterial isolates.

Brown-Jaque M, Calero-Cáceres W, Espinal P, Rodríguez-Navarro J, Miró E, González-López JJ, Cornejo T, Hurtado JC, Navarro F, Muniesa M.

Int J Antimicrob Agents. 2018 Mar;51(3):434-442. doi: 10.1016/j.ijantimicag.2017.11.014. Epub 2017 Nov 24.

6.

First Description of blaNDM-7 Carried on an IncX4 Plasmid in Escherichia coli ST679 Isolated in Spain.

Espinal P, Miró E, Segura C, Gómez L, Plasencia V, Coll P, Navarro F.

Microb Drug Resist. 2018 Mar;24(2):113-119. doi: 10.1089/mdr.2017.0039. Epub 2017 Jun 26.

PMID:
28650275
7.

Characterization of the Genetic Environment of the blaVEB-4 Gene, Associated with a Transposable Region in a Proteus mirabilis Clinical Isolate.

Espinal P, Miró E, Ramoneda L, Flores M, Rivera A, Coll P, Navarro F.

Microb Drug Resist. 2017 Oct;23(7):833-837. doi: 10.1089/mdr.2016.0262. Epub 2017 Mar 17.

PMID:
28304213
8.

Immunohistochemical study of the neural development transcription factors (TTF1, ASCL1 and BRN2) in neuroendocrine prostate tumours.

Rodríguez-Zarco E, Vallejo-Benítez A, Umbría-Jiménez S, Pereira-Gallardo S, Pabón-Carrasco S, Azueta A, González-Cámpora R, Espinal PS, García-Escudero A.

Actas Urol Esp. 2017 Oct;41(8):529-534. doi: 10.1016/j.acuro.2016.11.009. Epub 2017 Mar 9. English, Spanish.

PMID:
28285791
9.

Identification of Trypanosoma cruzi Discrete Typing Units (DTUs) in Latin-American migrants in Barcelona (Spain).

Abras A, Gállego M, Muñoz C, Juiz NA, Ramírez JC, Cura CI, Tebar S, Fernández-Arévalo A, Pinazo MJ, de la Torre L, Posada E, Navarro F, Espinal P, Ballart C, Portús M, Gascón J, Schijman AG.

Parasitol Int. 2017 Apr;66(2):83-88. doi: 10.1016/j.parint.2016.12.003. Epub 2016 Dec 7.

PMID:
27940065
10.

Loss of LPS is involved in the virulence and resistance to colistin of colistin-resistant Acinetobacter nosocomialis mutants selected in vitro.

Vila-Farrés X, Ferrer-Navarro M, Callarisa AE, Martí S, Espinal P, Gupta S, Rolain JM, Giralt E, Vila J.

J Antimicrob Chemother. 2015 Nov;70(11):2981-6. doi: 10.1093/jac/dkv244. Epub 2015 Aug 25.

PMID:
26311838
11.

Identification of NDM-1 in a Putatively Novel Acinetobacter Species ("NB14") Closely Related to Acinetobacter pittii.

Espinal P, Mosqueda N, Telli M, van der Reijden T, Rolo D, Fernández-Orth D, Dijkshoorn L, Roca I, Vila J.

Antimicrob Agents Chemother. 2015 Oct;59(10):6657-60. doi: 10.1128/AAC.01455-15. Epub 2015 Aug 10.

12.

In vitro selection of mutants resistant to ozenoxacin compared with levofloxacin and ciprofloxacin in Gram-positive cocci.

López Y, Tato M, Espinal P, Garcia-Alonso F, Gargallo-Viola D, Cantón R, Vila J.

J Antimicrob Chemother. 2015 Jan;70(1):57-61. doi: 10.1093/jac/dku375. Epub 2014 Sep 25.

PMID:
25261416
13.

Molecular characterization of NDM-1-producing Acinetobacter pittii isolated from Turkey in 2006.

Roca I, Mosqueda N, Altun B, Espinal P, Akova M, Vila J.

J Antimicrob Chemother. 2014 Dec;69(12):3437-8. doi: 10.1093/jac/dku306. Epub 2014 Aug 4. No abstract available.

PMID:
25096072
14.

In vitro activity of Ozenoxacin against quinolone-susceptible and quinolone-resistant gram-positive bacteria.

López Y, Tato M, Espinal P, Garcia-Alonso F, Gargallo-Viola D, Cantón R, Vila J.

Antimicrob Agents Chemother. 2013 Dec;57(12):6389-92. doi: 10.1128/AAC.01509-13. Epub 2013 Sep 30.

15.

Globally expanding carbapenemase finally appears in Spain: nosocomial outbreak of acinetobacter baumannii producing plasmid-encoded OXA-23 in Barcelona, Spain.

Mosqueda N, Espinal P, Cosgaya C, Viota S, Plasensia V, Alvarez-Lerma F, Montero M, Gómez J, Horcajada JP, Vila J, Roca I.

Antimicrob Agents Chemother. 2013 Oct;57(10):5155-7. doi: 10.1128/AAC.01486-13. Epub 2013 Jul 22.

16.

Spread of NDM-2-producing Acinetobacter baumannii in the Middle East.

Espinal P, Poirel L, Carmeli Y, Kaase M, Pal T, Nordmann P, Vila J.

J Antimicrob Chemother. 2013 Aug;68(8):1928-30. doi: 10.1093/jac/dkt109. Epub 2013 May 14. No abstract available.

PMID:
23674763
17.

Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.

García-de-la-Mària C, Pericas JM, Del Río A, Castañeda X, Vila-Farrés X, Armero Y, Espinal PA, Cervera C, Soy D, Falces C, Ninot S, Almela M, Mestres CA, Gatell JM, Vila J, Moreno A, Marco F, Miró JM; Hospital Clinic Experimental Endocarditis Study Group.

Antimicrob Agents Chemother. 2013 May;57(5):2319-25. doi: 10.1128/AAC.01921-12. Epub 2013 Mar 11.

18.

Characterization of resistance mechanisms and genetic relatedness of carbapenem-resistant Acinetobacter baumannii isolated from blood, Italy.

Migliavacca R, Espinal P, Principe L, Drago M, Fugazza G, Roca I, Nucleo E, Bracco S, Vila J, Pagani L, Luzzaro F.

Diagn Microbiol Infect Dis. 2013 Feb;75(2):180-6. doi: 10.1016/j.diagmicrobio.2012.11.002. Epub 2012 Dec 21.

PMID:
23265293
19.

Mass spectrometry: a revolution in clinical microbiology?

Lavigne JP, Espinal P, Dunyach-Remy C, Messad N, Pantel A, Sotto A.

Clin Chem Lab Med. 2013 Feb;51(2):257-70. Review.

PMID:
23072853
20.

First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain.

Espinal P, Macià MD, Roca I, Gato E, Ruíz E, Fernández-Cuenca F, Oliver A, Rodríguez-Baño J, Bou G, Tomás M, Vila J.

Antimicrob Agents Chemother. 2013 Jan;57(1):589-91. doi: 10.1128/AAC.01157-12. Epub 2012 Oct 15.

21.

The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.

Roca I, Espinal P, Vila-Farrés X, Vila J.

Front Microbiol. 2012 Apr 23;3:148. doi: 10.3389/fmicb.2012.00148. eCollection 2012.

22.

First identification of OXA-72 carbapenemase from Acinetobacter pittii in Colombia.

Montealegre MC, Maya JJ, Correa A, Espinal P, Mojica MF, Ruiz SJ, Rosso F, Vila J, Quinn JP, Villegas MV.

Antimicrob Agents Chemother. 2012 Jul;56(7):3996-8. doi: 10.1128/AAC.05628-11. Epub 2012 Apr 16.

23.

Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS.

Espinal P, Seifert H, Dijkshoorn L, Vila J, Roca I.

Clin Microbiol Infect. 2012 Nov;18(11):1097-103. doi: 10.1111/j.1469-0691.2011.03696.x. Epub 2011 Nov 15.

24.

Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces.

Espinal P, Martí S, Vila J.

J Hosp Infect. 2012 Jan;80(1):56-60. doi: 10.1016/j.jhin.2011.08.013. Epub 2011 Oct 4.

PMID:
21975219
25.

Analysis of genes encoding penicillin-binding proteins in clinical isolates of Acinetobacter baumannii.

Cayô R, Rodríguez MC, Espinal P, Fernández-Cuenca F, Ocampo-Sosa AA, Pascual A, Ayala JA, Vila J, Martínez-Martínez L.

Antimicrob Agents Chemother. 2011 Dec;55(12):5907-13. doi: 10.1128/AAC.00459-11. Epub 2011 Sep 26.

26.

Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center.

Espinal P, Fugazza G, López Y, Kasma M, Lerman Y, Malhotra-Kumar S, Goossens H, Carmeli Y, Vila J.

Antimicrob Agents Chemother. 2011 Nov;55(11):5396-8. doi: 10.1128/AAC.00679-11. Epub 2011 Aug 8.

27.

Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter.

Espinal P, Roca I, Vila J.

Future Microbiol. 2011 May;6(5):495-511. doi: 10.2217/fmb.11.30.

PMID:
21585259
28.

First identification and characterization of an AdeABC-like efflux pump in Acinetobacter genomospecies 13TU.

Roca I, Espinal P, Martí S, Vila J.

Antimicrob Agents Chemother. 2011 Mar;55(3):1285-6. doi: 10.1128/AAC.01142-10. Epub 2011 Jan 3.

29.

Identification of SHV-type and CTX-M-12 extended-spectrum beta-lactamases (ESBLs) in multiresistant Enterobacteriaceae from Colombian Caribbean hospitals.

Espinal P, Garza-Ramos U, Reyna F, Rojas-Moreno T, Sanchez-Perez A, Carrillo B, Martinez P, Mattar S, Silva-Sanchez J.

J Chemother. 2010 Jun;22(3):160-4.

PMID:
20566419
30.

CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii.

Roca I, Marti S, Espinal P, Martínez P, Gibert I, Vila J.

Antimicrob Agents Chemother. 2009 Sep;53(9):4013-4. doi: 10.1128/AAC.00584-09. Epub 2009 Jul 6.

31.

In vitro activity of ceftobiprole against Acinetobacter baumannii clinical isolates.

Marti S, Sánchez-Céspedes J, Espinal P, Vila J.

Int J Antimicrob Agents. 2009 Sep;34(3):265-7. doi: 10.1016/j.ijantimicag.2009.03.015. Epub 2009 May 5.

PMID:
19406625
32.

ISEcp1-mediated transposition of qnrB-like gene in Escherichia coli.

Cattoir V, Nordmann P, Silva-Sanchez J, Espinal P, Poirel L.

Antimicrob Agents Chemother. 2008 Aug;52(8):2929-32. doi: 10.1128/AAC.00349-08. Epub 2008 Jun 2.

33.

Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.

Marti S, Sánchez-Céspedes J, Blasco MD, Ruiz M, Espinal P, Alba V, Fernández-Cuenca F, Pascual A, Vila J.

Antimicrob Agents Chemother. 2008 Aug;52(8):2955-8. doi: 10.1128/AAC.00072-08. Epub 2008 May 27.

34.

Characterization of the carbapenem-hydrolyzing oxacillinase OXA-58 in an Acinetobacter phenon 6/ct13TU clinical isolate.

Marti S, Sánchez-Céspedes J, Blasco MD, Espinal P, Ruiz M, Alba V, Vila J.

Diagn Microbiol Infect Dis. 2008 Aug;61(4):468-70. doi: 10.1016/j.diagmicrobio.2008.03.014. Epub 2008 May 15.

PMID:
18485655
35.

[Molecular characterization of an outbreak caused by CTX-M-12-producing Klebsiella pneumoniae in a Colombian hospital's neonatal intensive care unit].

Mantilla JR, Reguero MT, González EB, García IA, Leal AL, Espinal PA, Alpuche C, Valderrama IA, Garzón MI, Olarte NM.

Biomedica. 2006 Sep;26(3):408-14. Spanish.

PMID:
17176004
36.

[Molecular epidemiology of nosocomial infection by extended-spectrum beta-lactamases-producing Klebsiella pneumoniae].

Espinal PA, Mantilla JR, Saavedra CH, Leal AL, Alpuche C, Valenzuela EM.

Biomedica. 2004 Sep;24(3):252-61. Spanish.

PMID:
15551877

Supplemental Content

Loading ...
Support Center